BioForward proudly presents the BioForward Wisconsin’s inaugural WI Biohealth Investor Portfolio Report, highlighting the funding wins and milestone achievements of biohealth companies across our state....
The prospective, head-to-head trial demonstrated that the company’s Oncoguard® Liver blood test delivers superior early-stage and overall sensitivity for hepatocellular carcinoma (HCC) — the most common form of liver cancer — compared to the current standard of care....
The UW–Madison and the Morgridge Institute for Research have built a nexus of researchers who are pushing biological optical microscopy — including and beyond fluorescence — at all of its edges. Working together and with collaborators across the globe, these labs are engineering transformative label-free...
Speaking at WTC Early Stage Symposium in Madison during her third day on the job, Brickerman discussed how her past work with startup accelerator gener8tor will shape her approach to leading the organization....
Milwaukee developer Mandel Group announced Tuesday it has completed assembling a $65 million financing package to construct Element Collective, a 197-unit workforce housing development located in University Research Park....
Innovators from across the state gathered Tuesday at Monona Terrace Community and Convention Center as the Wisconsin Technology Council presented the 2025 Wisconsin Innovation Awards....
Patrick Tetzlaff and Brian Leadingham, run Design Department, Inc., a Franklin-based product development consultancy. The team will present the spherical canister during the Elevator Pitch Olympics, part of the Early Stage Symposium presented by the WTC....
Sahab Aslam, founder of Vectorify Labs and the AI sector lead at the Harvard Business School Alumni Angels of New York, was a featured speaker during yesterday’s WTC luncheon in Madison....
EMP-012’s novel mechanism of action, discovered by Empirico, targets a distinct inflammatory pathway introducing the potential for a therapeutic approach that is agnostic of baseline type 2 inflammation, smoking or co-morbid disease. ...
Prof. Burgess, Senior Oncology Advisor to FAR Biotech, is the James D. Watson Professor Emeritus of Oncology at UW–Madison’s McArdle Laboratory for Cancer Research....
The Wisconsin Alumni Association celebrated six remarkable young alumni at its Forward Award Recognition ceremony on October 9, honoring Badgers who are translating their UW–Madison education into world-changing impact....
“Our platforms eliminate lengthy optimization, supporting a seamless path from initial discovery to clinical ADC candidates,” said Bonnie Hammer, Executive VP R&D of Invenra....
UW–Madison introduces new initiative, the Wisconsin Exchange: Pluralism in Practice, which aims to help students, faculty and staff learn to engage, live and lead in a polarized world. ...
The trademark event was the first in over 650 science engagement events that will take place across the state during the 10 days Governor Evers has declared Wisconsin Science Week from Oct. 16 to Oct. 26. This year’s festival will explore the theme of “Rock...
Under Tom’s leadership, the Wisconsin Technology Council created the premier statewide conferences aimed at entrepreneurs and investors, the Early Stage Symposium and the Wisconsin Entrepreneur’s Network. These events bring together hundreds of people interested in high growth potential startups each year....
Kauten was an early backer, founder and executive in a handful of Wisconsin biotech sciences, including Promega, PanVera, Mirus Bio, Quintessence Biosciences and Lucigen. He is known for creating companies that reach successful “exits,” meaning they were sold or acquired by larger firms to the...
A flagship financial aid program at the University of Wisconsin–Madison that provides generous support to in-state students from low- to moderate-income families increases student retention by several percentage points, according to new research. ...
One MRD test now being used in clinical practice is the Oncodetect™ test±, launched by Exact Sciences in early 2025 and now covered by Medicare....
Using fruit flies, University of Wisconsin–Madison researchers have developed a new model for investigating the genetic drivers of a rare but aggressive brain tumor in children. The work has already identified potential treatment targets for the deadly cancer that has previously had few therapeutic options....
Sixty-one companies will pitch to potential investors and others during the in-person Wisconsin Early Stage Symposium, set for Nov. 5-6 in Madison. That includes 20 companies selected by conference organizers for the newly added “Open Mic” Quick Pitch on the morning of Nov. 5; 22...